Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2021 | Areas of unmet need in mUC

Thomas Powles, MBBS, MRCP, MD, Barts Cancer Institute, London, UK, provides an overview of the areas of unmet need for patients with metastatic urothelial carcinoma (mUC), including a better understanding of how to use novel agents in earlier settings, improving treatment combinations as well as identifying biomarkers for response to immunotherapy. This interview took place at the European Society for Medical Oncology (ESMO) 2021 congress.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.